Track topics on Twitter Track topics that are important to you
NEW YORK, Oct. 19, 2016 /PRNewswire/ -- Plaintiffs who allegedly suffered serious kidney injuries, including chronic kidney disease or kidney failure, related to the use of Nexium or another proton pump inhibitor have asked a judicial panel to consolidate all such federally-filed claims before a single judge in the U.S. District Court, Middle District of Louisiana. According to a Motion for Transfer filed with the U.S. Judicial Panel for Multidistrict Litigation (JPML) on October 17th, at least 15 proton pump inhibitor lawsuits involving acute interstitial nephritis, chronic kidney disease and kidney failure are already pending in federal courts around the U.S. However, the moving plaintiffs contend that thousands of additional cases are currently under investigation, and assert that hundreds of new lawsuits will be filed in the coming months. (In re: Proton-Pump Inhibitor Products Liability Litigation – MDL No. 2757)
"Our Firm is actively filing kidney injury lawsuits on behalf of individuals allegedly harmed due to their use of proton pump inhibitors. We believe that the litigation involving these medications has the potential to be large, and consolidation in a single court will ensure that these cases progress in the most efficient manner possible," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP. The Firm continues to offer free legal reviews to individuals who were diagnosed with chronic kidney disease, kidney failure, acute kidney injury, or acute interstitial nephritis following long-term use of prescription or over-the-counter proton pump inhibitors.
Proton Pump Inhibitor Lawsuits
Proton pump inhibitors are a class of heartburn drugs indicated for the short-term treatment of gastroesophageal reflux disease (GERD) and other stomach problems related to the excess production of gastric acid. Prescription medications in this class include:
Nexium 24HR, Prilosec OTC, PrevAcid 24HR, and other over-the counter brands are also available.
According to the October 17th Motion for Transfer, all of the proton pump inhibitor lawsuits currently pending in federal courts claim that the drugs' manufacturers failed to adequately warn consumers that use of prescription and/or over-the-counter versions could cause irreparable harm to the kidneys. Plaintiffs assert that without centralization, there exists "the possibility of inconsistent pretrial rulings exists, especially with respect to the proper scope and extent of discovery, causation, and other factual and legal issues."
The Motion points out that one of the pending proton pump inhibitor lawsuits was filed in the Middle District of Louisiana, and notes that there are currently no other multidistrict litigations underway in the jurisdiction. As such, plaintiffs contend that the District possesses the "proper resources and time necessary to manage this complex litigation." They have also proposed the District of New Jersey, the Southern District of Illinois, the District of Kansas or the Western District of Louisiana as possible alternative venues for the centralized proceeding.
Proton pump inhibitor patients who were diagnosed with serious kidney complications may be able to take legal action of their own. To learn more, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2016 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/proton-pump-inhibitor-lawsuit-plaintiffs-seek-consolidation-of-federal-kidney-injury-claims-bernstein-liebhard-llp-reports-300347658.html
SOURCE Bernstein Liebhard LLPNEXT ARTICLE
Chronic kidney disease (CKD), also known as chronic renal disease, is a progressive loss in renal function over a period of months or years. The symptoms of worsening kidney function are non-specific, and might include feeling generally unwell and experi...
Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...